Search

Your search keyword '"Chung, K F."' showing total 1,149 results

Search Constraints

Start Over You searched for: Author "Chung, K F." Remove constraint Author: "Chung, K F."
1,149 results on '"Chung, K F."'

Search Results

6. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

7. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology

8. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology

9. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology

10. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology

16. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology.

17. Efficacy of lifestyle medicine on sleep quality: A meta-analysis of randomized controlled trials.

20. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

21. Identification of oropharyngeal microbiome-driven asthma and wheezing clusters in children

22. Sputum metagenomics of U-BIOPRED asthma cohort: link to severity and granulocytic inflammation

24. Radiomics for severe asthma phenotyping and endotyping

27. The regulation of IL33 following smoking cessation

35. Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation

36. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

40. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

42. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline

44. Immune modulation via T regulatory cell enhancement: disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases - An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

45. Immune modulation via T regulatory cell enhancement: disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases - An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

46. Effects of a group-based lifestyle medicine for depression: A pilot randomized controlled trial

47. Immune modulation via T regulatory cell enhancement: disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases - An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

48. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

49. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

50. Characteristics and treatment regimens across ERS SHARP severe asthma registries

Catalog

Books, media, physical & digital resources